Flavocoxid, dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, exhibits neuroprotection in rat model of ischaemic stroke

Pharmacology Biochemistry and Behavior

Volumn 120, Issue , 2014, Pages 33-42

  Singh, Dhirendra Pratap ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cyclooxygenase; Interleukin; Lipoxygenase; Neuroprotection; Nuclear factor kappa B; Tumour necrosis factor

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BIOGENIC AMINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; FLAVOCOXID; FLUOXETINE; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIMBREL; NITRITE; NORADRENALIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RIVASTIGMINE; SEROTONIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CATECHIN; CYTOKINE; DRUG COMBINATION; LIPOXYGENASE INHIBITOR; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY PERFUSION; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CHEMICAL ANALYSIS; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL RAT; INCLINED BEAM WALKING TEST; LIPID PEROXIDATION; LOCOMOTION; LONG TERM MEMORY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROCHEMISTRY; NEUROPROTECTION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK; ANIMAL; ANIMAL BEHAVIOR; COGNITION; DRUG COMBINATION; DRUG EFFECTS; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; PATHOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; STROKE; WISTAR RAT;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CATECHIN; COGNITION; CYCLOOXYGENASE 2 INHIBITORS; CYTOKINES; DEPRESSION; DRUG COMBINATIONS; ISCHEMIC ATTACK, TRANSIENT; LIPOXYGENASE INHIBITORS; MALE; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; STROKE;

EID: 84895524306     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.02.006     Document Type: Article

References (69)

1. M.M. Abd El Mohsen, G. Kuhnle, A.R. Rechner, H. Schroeter, S. Rose, and P. Jenner et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion Free Radic Biol Med 33 2002 1693 1702
2. F. Aktan iNOS-mediated nitric oxide production and its regulation Life Sci 75 2004 639 653
3. D. Altavilla, F. Squadrito, A. Bitto, F. Polito, B.P. Burnett, and V. Di Stefano et al. Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages Br J Pharmacol 157 2009 1410 1418
4. M. Barry, R.A. Cahill, G. Roche-Nagle, T.G. Neilan, A. Treumann, and J.H. Harmey et al. Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer Ir J Med Sci 178 2009 201 208
5. J.B. Bederson, L.H. Pitts, M. Tsuji, M.C. Nishimura, R.L. Davis, and H. Bartkowski Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination Stroke 17 1986 472 476
6. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1999 1127 1137
7. V.D. Bianca, S. Dusi, E. Bianchini, I. Dal Pra, and F. Rossi beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease J Biol Chem 274 1999 15493 15499
8. J. Birks, B. McGuinness, and D. Craig Rivastigmine for vascular cognitive impairment Cochrane Database Syst Rev 5 2013 CD004744 10.1002/14651858. CD004744.pub3
9. M.L. Block NADPH oxidase as a therapeutic target in Alzheimer's disease BMC Neurosci 9 2008 S8
10. B.P. Burnett, Q. Jia, Y. Zhao, and R.M. Levy A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation J Med Food 10 2007 442 451
11. B.P. Burnett, S. Silva, M.H. Mesches, S. Wilson, and Q.I. Jia Safety evaluation of a combination, defined extract of Scutellaria baicalensis and Acacia catechu J Food Biochem 31 2007 797 825
12. B.P. Burnett, A. Bitto, D. Altavilla, F. Squadrito, R.M. Levy, and L. Pillai Flavocoxid inhibits phospholipase A2, peroxidase moieties of the cyclooxygenases (COX), and 5-lipoxygenase, modifies COX-2 gene expression, and acts as an antioxidant Mediators Inflamm 2011 385780 10.1155/2011/385780
13. N. Chalasani, R. Vuppalanchi, V. Navarro, R. Fontana, H. Bonkovsky, and H. Barnhart et al. Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series Ann Intern Med 156 2012 857 860
14. F. Chollet, J. Tardy, J.F. Albucher, C. Thalamas, E. Berard, and C. Lamy et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial Lancet Neurol 10 2011 123 130
15. A. Claiborne Catalase activity CRC handbook of methods for oxygen radical research 1985 CRC Press Boca Raton, FL 283 284
16. E.S. Connolly Jr., C.J. Winfree, T.A. Springer, Y. Naka, H. Liao, and S.D. Yan et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke J Clin Invest. 97 1996 209 216
17. A. Dhir, K.K. Akula, and S.K. Kulkarni Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats Prog Neuropsychopharmacol Biol Psychiatry 32 2008 835 843
18. G.A. Donnan, J.C. Baron, H. Ma, and S.M. Davis Penumbral selection of patients for trials of acute stroke therapy Lancet Neurol 8 2009 261 269
19. G.L. Ellman Tissue sulfhydryl groups Arch Biochem Biophys 82 1959 70 77
20. G.L. Ellman, K.D. Courtney, V. Andres Jr., and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem Pharmacol 7 1961 88 95
21. F. Fang, Y.J. Han, and Z.Q. Cui The protective effects of tea catechins on the injury of cerebral ischemia and reperfusion in rats Zhongguo Zhong Yao Za Zhi 26 2001 777 780
22. W. Fang, P. Lv, X. Geng, E. Shang, Q. Yang, and L. Sha et al. Penetration of verapamil across blood brain barrier following cerebral ischemia depending on both paracellular pathway and P-glycoprotein transportation Neurochem Int 62 2013 23 30
23. V. Gaur, A. Aggarwal, and A. Kumar Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain Eur J Pharmacol 616 2009 147 154
24. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1982 131 138
25. N. Himori, H. Watanabe, N. Akaike, M. Kurasawa, J. Itoh, and Y. Tanaka Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability J Pharmacol Methods 23 1990 311 327
26. A.J. Hunter, J. Hatcher, D. Virley, P. Nelson, E. Irving, and S.J. Hadingham et al. Functional assessments in mice and rats after focal stroke Neuropharmacology 39 2000 806 816
27. C. Iadecola, and J. Anrather The immunology of stroke: from mechanisms to translation Nat Med 17 2011 796 808
28. Q. Jia Generating and screening a natural product library for cyclooxygenase and lipoxygenase dual inhibitors R. Atta ur, Studies in natural products chemistry 2003 Elsevier 643 718
29. Z. Jin, J. Wu, S.Y. Oh, K.W. Kim, and B.S. Shin The effect of stress on stroke recovery in a photothrombotic stroke animal model Brain Res 1363 2010 191 197
30. J. Jingtao, S. Sato, and N. Yamanaka Changes in cerebral blood flow and blood brain barrier in the gerbil hippocampal CA1 region following repeated brief cerebral ischemia Med Electron Microsc 32 1999 175 183
31. M. Kauhanen, J.T. Korpelainen, P. Hiltunen, E. Brusin, H. Mononen, and R. Maatta et al. Poststroke depression correlates with cognitive impairment and neurological deficits Stroke 30 1999 1875 1880
32. T.E. King [58] Preparation of succinate dehydrogenase and reconstitution of succinate oxidase Ronald W. Estabrook, MEP Methods in enzymology 1967 Academic Press 322 331
33. T.E. King, and R.L. Howard Preparations and properties of soluble NADH dehydrogenases from cardiac muscle Ronald W. Estabrook, MEP Methods in enzymology 1967 Academic Press 275 294
34. A. Klegeris, and P.L. McGeer Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity Neurobiol Aging 23 2002 787 794
35. Y. Kono Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase Arch Biochem Biophys 186 1978 189 195
36. R.M. Levy, R. Saikovsky, E. Shmidt, A. Khokhlov, and B.P. Burnett Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study Nutr Res 29 2009 298 304
37. R.M. Levy, L. Pillai, and B.P. Burnett Nutritional benefits of flavocoxid in patients with osteoarthritis: efficacy and safety Nutr Diet Suppl 2010 2 2010 27 38
38. J. Martel-Pelletier, D. Lajeunesse, P. Reboul, and J.P. Pelletier Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis 62 2003 501 509
39. S. Messina, A. Bitto, M. Aguennouz, A. Mazzeo, A. Migliorato, and F. Polito et al. Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone Exp Neurol 220 2009 349 358
40. L. Minghetti Role of COX-2 in inflammatory and degenerative brain diseases Subcell Biochem 42 2007 127 141
41. R.G. Morris, P. Garrud, J.N. Rawlins, and J. O'Keefe Place navigation impaired in rats with hippocampal lesions Nature 297 1982 681 683
42. Y. Murata, M. Kimura, and R.G. Robinson Does cognitive impairment cause post-stroke depression? Am J Geriatr Psychiatry 8 2000 310 317
43. K. Narasimhalu, S. Effendy, C.H. Sim, J.M. Lee, I. Chen, and S.B. Hia et al. A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease Acta Neurol Scand 121 2010 217 224
44. S. Nogawa, F. Zhang, M.E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J Neurosci 17 1997 2746 2755
45. S. Paolucci, I. Bureca, M. Multari, U. Nocentini, and A. Matano An open-label pilot study of the use of rivastigmine to promote functional recovery in patients with unilateral spatial neglect due to first ischemic stroke Funct Neurol 25 2010 195 200
46. B.A. Patel, M. Arundell, K.H. Parker, M.S. Yeoman, and D. O'Hare Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection J Chromatogr B Analyt Technol Biomed Life Sci 818 2005 269 276
47. J.W. Phillis, L.A. Horrocks, and A.A. Farooqui Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders Brain Res Rev 52 2006 201 243
48. L. Pillai, B.P. Burnett, and R.M. Levy GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin Curr Med Res Opin 26 2010 1055 1063
49. F. Polito, A. Bitto, N. Irrera, F. Squadrito, C. Fazzari, and L. Minutoli et al. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis Br J Pharmacol 161 2010 1002 1011
50. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
51. S. Shapira, M. Sapir, A. Wengier, E. Grauer, and T. Kadar Aging has a complex effect on a rat model of ischemic stroke Brain Res 925 2002 148 158
52. H.Y. Shi, F.J. Lv, S.T. Zhu, Q.G. Wang, and S.T. Zhang Dual inhibition of 5-LOX and COX-2 suppresses esophageal squamous cell carcinoma Cancer Lett 309 2011 19 26
53. D.P. Singh, and K. Chopra Verapamil augments the neuroprotectant action of berberine in rat model of transient global cerebral ischemia Eur J Pharmacol 720 2013 98 106
54. G.L. Sottocasa, B. Kuylenstierna, L. Ernster, and A. Bergstrand An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study J Cell Biol 32 1967 415 438
55. G. Spalletta, P. Bossu, A. Ciaramella, P. Bria, C. Caltagirone, and R.G. Robinson The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines Mol Psychiatry 11 2006 984 991
56. M. Stamenkovic, S. Schindler, and S. Kasper Therapy of post-stroke depression with fluoxetine. A pilot project Nervenarzt 67 1996 62 67
57. K. Takahashi, H. Murasawa, K. Yamaguchi, M. Yamada, A. Nakatani, and M. Yoshida et al. Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression Behav Brain Res 216 2011 46 52
58. G.H. Taylor, J. Todman, and N.M. Broomfield Post-stroke emotional adjustment: a modified social cognitive transition model Neuropsychol Rehabil 21 2011 808 824
59. P. Teschendorf, S.A. Padosch, F. Spohr, M. Albertsmeier, A. Schneider, and P. Vogel et al. Time course of caspase activation in selectively vulnerable brain areas following global cerebral ischemia due to cardiac arrest in rats Neurosci Lett 448 2008 194 199
60. V. Tiwari, and K. Chopra Resveratrol abrogates alcohol-induced cognitive deficits by attenuating oxidative-nitrosative stress and inflammatory cascade in the adult rat brain Neurochem Int 62 2013 861 869
61. M. Tuzcu, and G. Baydas Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats Eur J Pharmacol 537 2006 106 110
62. R. Vataja, T. Pohjasvaara, R. Mantyla, R. Ylikoski, M. Leskela, and H. Kalska et al. Depression-executive dysfunction syndrome in stroke patients Am J Geriatr Psychiatry 13 2005 99 107
63. G.F. Wang, Z.F. Wu, L. Wan, Q.T. Wang, and F.M. Chen Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells Pharmacology 77 2006 71 77
64. E.D. Wills Mechanisms of lipid peroxide formation in tissues. Role of metals and haematin proteins in the catalysis of the oxidation unsaturated fatty acids Biochim Biophys Acta 98 1965 238 251
65. B. Yan, J. He, H. Xu, Y. Zhang, X. Bi, and S. Thakur et al. Quetiapine attenuates the depressive and anxiolytic-like behavioural changes induced by global cerebral ischemia in mice Behav Brain Res 182 2007 36 41
66. L. Zhang, F. Fu, X. Zhang, M. Zhu, T. Wang, and H. Fan Escin attenuates cognitive deficits and hippocampal injury after transient global cerebral ischemia in mice via regulating certain inflammatory genes Neurochem Int 57 2010 119 127
67. B.G. Zhu, Y. Sun, Z.Q. Sun, G. Yang, C.H. Zhou, and R.S. Zhu Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke CNS Neurosci Ther 18 2012 530 535
68. H. Zhu, Z. Wang, Y. Xing, Y. Gao, T. Ma, and L. Lou et al. Baicalin reduces the permeability of the blood-brain barrier during hypoxia in vitro by increasing the expression of tight junction proteins in brain microvascular endothelial cells J Ethnopharmacol 141 2012 714 720
69. L. Zvejniece, B. Svalbe, E. Liepinsh, E. Pulks, and M. Dambrova The sensorimotor and cognitive deficits in rats following 90- and 120-min transient occlusion of the middle cerebral artery J Neurosci Methods 208 2012 197 204